Bleakley Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20M Buy
155,898
+26,681
+21% +$3.12M 0.26% 74
2026
Q1
$15.5M Buy
129,217
+2,930
+2% +$338K 0.24% 73
2025
Q4
$13.3M Buy
126,287
+54,840
+77% +$5.15M 0.23% 77
2025
Q3
$6M Buy
71,447
+1,732
+2% +$143K 0.14% 135
2025
Q2
$5.52M Sell
69,715
-3,206
-4% -$255K 0.14% 139
2025
Q1
$6.55M Sell
72,921
-9,565
-12% -$893K 0.21% 92
2024
Q4
$8.21M Buy
82,486
+772
+0.9% +$79.6K 0.25% 71
2024
Q3
$9.28M Sell
81,714
-83,306
-50% -$9.9M 0.28% 57
2024
Q2
$20.4M Buy
165,020
+81,484
+98% +$10.5M 0.59% 28
2024
Q1
$11M Buy
83,536
+3,036
+4% +$374K 0.32% 60
2023
Q4
$8.78M Buy
80,500
+122
+0.2% +$12.7K 0.28% 67
2023
Q3
$8.27M Sell
80,378
-78,759
-49% -$8.49M 0.29% 68
2023
Q2
$18.4M Sell
159,137
-18,073
-10% -$2.05M 0.57% 32
2023
Q1
$18.9M Buy
177,210
+5,626
+3% +$607K 0.63% 27
2022
Q4
$19M Buy
+171,584
New +$17.5M 0.68% 24

Other funds holding MRK

Bleakley Financial Group's MRK Position: Q2 2026 in Review

Bleakley Financial Group increased its Merck (MRK) stake by 21% in Q2 2026, buying an estimated $3.12M and bringing the position to 155,898 shares worth $20M. The position accounts for 0.26% of the portfolio, ranked #74.

Bleakley Financial Group first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $20.4M in Q2 2024. 3,832 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Bleakley Financial Group held 155,898 shares of Merck worth $20M as of Q2 2026.
  • Bleakley Financial Group bought 26,681 Merck shares in Q2 2026, an estimated $3.12M.
  • Merck made up 0.26% of Bleakley Financial Group's portfolio in Q2 2026, its #74 holding.
  • Bleakley Financial Group first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Bleakley Financial Group's Merck position peaked at $20.4M in Q2 2024.
  • 3,832 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.